InsidersTradesSigma
Follow the 테라젠이텍스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has recorded 12 reports. Market capitalisation: €72bn. The latest transaction was disclosed on 19 March 2026 (Purchase). Among the most active insiders: 테라젠이텍스. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Teragen Etex es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones innovadoras en el campo de la biotecnología.